Human medicines
Recall "Melphalan Koanaa 50 mg i.v. Powder and solvent for solution for injection or solution for infusion" (active ingredient melphalan)
Vibravenös
The marketing authorization holder has informed its supplied customers in a letter dated August 10, 2017, that a batch of Vibravenous - Ampoules with…
Melphalan
"Koanaa Healthcare GmbH" has informed its customers in a letter dated August 10, 2017, that the further marketing of "Melphalan Koanaa 50 mg i.v.…
Quassia Similiaplex
"Pascoe Pharm. Präparate GmbH" as the holder of the registration as a homeopathic medicinal speciality of "Quassia Similiaplex drops" has informed its…
Edronax
The marketing authorization holder has informed its supplied customers in a letter dated July 25, 2017, that a test result within the scope of a…
Buerlecithin
The marketing authorization holder has informed its supplied customers in a letter dated July 04, 2017, that individual bottles filled with distilled…
Mucosolvan Lutschpastillen
The marketing authorization holder has informed its supplied customers in a letter dated June 21, 2017, that in the course of stability tests a trend…
Trobalt
The marketing authorization holder has informed its supplied customers in a letter dated 23.06.2017 that due to the global decision of the company,…
Elotrace
The marketing authorization holder has informed its supplied customers in a letter dated May 23, 2017, that increased black visible particles have…
Albiomin
The marketing authorization holder has informed its supplied customers in a letter dated April 27, 2017, that the affected batches are being recalled…
